bpc-157 safety human – Mark Hyman, MD bpc-157 safety human study and

Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500

This schedule is anecdotal and is not a recommendation for human use

Your provider determines whether peptide therapy may be appropriate based on your individual circumstances and treatment objectives

GHK-Cu is sold for laboratory research use only

Please consult with your veterinarian for further questions about Cyanocobalamin injections and whether the product is appropriate for your pet

Service levels excellent